Obesity start-up Adipogen wins VC funding boost
07 January, 2004 by Graeme O'NeillBrisbane biomedical company Adipogen has received a new injection of venture capital to pursue a novel therapy for obesity that would involve blocking the proliferation of fat-storage cells, or adipocytes.
Meditech secures deal with Danish firm
19 December, 2003 by Melissa TrudingerMeditech Research (ASX:MTR) has ended the year with the achievement of a major milestone, entering into an agreement with Danish biotechnology company Novozymes.
Cytopia claims positive results from anti-cancer trials
17 December, 2003 by Melissa TrudingerMedica Holdings (ASX:MCA) subsidiary Cytopia says it is firmly on the path to clinical trials with its anti-cancer molecule, after getting positive results from animal studies.
Prana Alzheimer's drug confirms therapeutic promise
16 December, 2003 by Graeme O'NeillA Phase II clinical study under way in Melbourne has confirmed the promise of metal-chelating agents for treating -- and perhaps even preventing -- the devastating neurogenerative disorder Alzheimer's disease.
Bionomics signs with US ally
15 December, 2003 by Graeme O'NeillAdelaide biotechnology company Bionomics (ASX:BNO, US OTC:BMICY) has found a friendly American bloodhound to help it track down new genes involved in epilepsy -- the Brigham and Women's Hospital in Boston.
NIH awards Melbourne researcher US$1.7m
01 December, 2003 by Graeme O'NeillMelbourne University epilepsy investigator Dr Steve Petrou has received a prestigious National Institutes of Health grant to study what happens in the brain of a transgenic mouse that exhibits human-like epileptic seizures.
Monash, Schering buddy up to research male disorders
27 November, 2003 by Graeme O'NeillMonash University and big German pharmaceutical company Schering AG have announced a collaborative research and licensing agreement to develop new therapies for prostate disease, male infertility, and new male contraceptives.
WEHI opens Bundoora Biotechnology Centre
18 November, 2003 by Melissa TrudingerAustralia's oldest medical research institution, the Walter and Eliza Hall Institute of Medical Research, has made a major move into the biotechnology arena with the opening of its AUD$27.5 million Biotechnology Centre.
Polartechnics in US distribution deal
14 November, 2003 by Melissa TrudingerSydney-based devices company Polartechnics (ASX:PLT) has signed a heads of agreement with US company Open Systems Imaging (OSI) to market and sell its melanoma detection and monitoring system SolarScan in the US.
New clinical trials lab opens for business
13 November, 2003 by Melissa TrudingerMelbourne clinical trials group Cancer Trials Australia (CTA) opened a new state-of-the-art laboratory on Wednesday, to complement other clinical trials services offered by the group.
Progen sells unit to NZ supplier
12 November, 2003 by Melissa TrudingerProgen (ASX:PGL) has sold its life sciences business unit to New Zealand-based Global Science and Technology (GST) for AUD$1.2 million.
'Eating machine' helps ID insulin activity
04 November, 2003 by Graeme O'NeillDiabetes researchers at Sydney's Garvan Institute have identified a gene that plays a key role in cellular sensitivity to insulin -- and which could be a target for anti-obesity drugs.
Peter Mac cancer therapy shows high promise
22 October, 2003 by Graeme O'NeillScientists at Melbourne's Peter MacCallum Cancer Research Centre have demonstrated an ingenious strategy for boosting and focusing the body's immune defences that causes dramatic regression of tumours in mice.
Bionomics files for new breast cancer test patents
21 October, 2003 by Graeme O'NeillAdelaide biotech Bionomics (ASX:BNO) has filed a provisional patent on a new method of determining the prognosis for women with early-stage breast cancer.
Cellestis firms up Japanese deal
20 October, 2003 by Melissa TrudingerDiagnostic company Cellestis has completed an amendment to its distribution agreement with Japanese company Nichirei, covering price and minimum volumes for its second generation TB test QuantiFERON-TB GOLD.
